Hypercalcemia of malignancy: Cancer treatment can be a cause as well
Clinical Nephrology · 2024
DOI: 10.5414/cn111403 ↗Kurz gefasst
Fallbericht in der Zeitschrift Clinical Nephrology, 2024. Verfasst von Hassan Izzedine und 4 weiteren Autor:innen. Hauptthemen laut MEDLINE: Hypercalcemia, Carcinoma, Squamous Cell. Die Arbeit wurde bisher 1-mal zitiert (Crossref).
Abstract (Originalsprache)
While the incidence of hypercalcemia of malignancy (HCM) is on the decline, it still occurs in up to 30% of patients with cancer. Immune checkpoint inhibitor (ICI)-related hypercalcemia is becoming increasingly recognized. We describe a case of cemiplimab-induced hypercalcemia in a patient with metastatic squamous cell carcinoma of the earlobe and discuss a management algorithm for HCM. Timely diagnosis and management of HCM is critical for optimal care and the prevention of complications.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Zitieren
APA
Izzedine, H., Attieh, R. M., Begum, F., Cheung, Y. M., & Jhaveri, K. D. (2024). Hypercalcemia of malignancy: Cancer treatment can be a cause as well. Clinical Nephrology. https://doi.org/10.5414/cn111403
Vancouver
Izzedine H, Attieh RM, Begum F, Cheung YM, Jhaveri KD. Hypercalcemia of malignancy: Cancer treatment can be a cause as well. Clinical Nephrology. 2024. doi:10.5414/cn111403
BibTeX
@article{Izzedine2024,
author = {Izzedine, Hassan and Attieh, Rose Mary and Begum, Farhana and Cheung, Yee-Ming Melody and Jhaveri, Kenar D},
title = {Hypercalcemia of malignancy: Cancer treatment can be a cause as well},
journal = {Clinical Nephrology},
year = {2024},
doi = {10.5414/cn111403}
}
EUVIMED